Citation 82232

KAM,TS: SIM,KM: KOYANO,T: TOYOSHIMA,M: HAYASHI,M: KOMIYAMA,K:. (1998). CYTOTOXIC AND LEISHMANICIDAL AMINOGLYCOSTEROIDS AND AMINOSTEROIDS FROM HOLARRHENA CURTISII.. 61(11)

Citation Details

TitleCYTOTOXIC AND LEISHMANICIDAL AMINOGLYCOSTEROIDS AND AMINOSTEROIDS FROM HOLARRHENA CURTISII.
AuthorsKAM,TS: SIM,KM: KOYANO,T: TOYOSHIMA,M: HAYASHI,M: KOMIYAMA,K:
Year1998
Volume61
Issue11

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Holarrhena curtisii (APOCYNACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
HOLACURTINE
None
2
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
3
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE
ACTIVE
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE
ACTIVE
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE
ACTIVE
8
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE
ACTIVE
9Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
HOLACURTINE,N-DEMETHYL:
None
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,N-DEMETHYL:
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,N-DEMETHYL:
ACTIVE
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,N-DEMETHYL:
WEAK ACTIVITY
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,N-DEMETHYL:
ACTIVE
14
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,N-DEMETHYL:
ACTIVE
15Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HOLACURTINE,17-EPI:
None
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI:
ACTIVE
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI:
WEAK ACTIVITY
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI:
WEAK ACTIVITY
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI:
WEAK ACTIVITY
20
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI:
WEAK ACTIVITY
21Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HOLACURTINE,17-EPI-N-DEMETHYL:
None
22
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI-N-DEMETHYL:
ACTIVE
23
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI-N-DEMETHYL:
WEAK ACTIVITY
24
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI-N-DEMETHYL:
WEAK ACTIVITY
25
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI-N-DEMETHYL:
WEAK ACTIVITY
26
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINE,17-EPI-N-DEMETHYL:
WEAK ACTIVITY
27Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HOLACURTINOL
None
28
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINOL
ACTIVE
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINOL
WEAK ACTIVITY
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINOL
WEAK ACTIVITY
31
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINOL
WEAK ACTIVITY
32
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLACURTINOL
WEAK ACTIVITY
33Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
HOLAMINE
None
34
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLAMINE
ACTIVE
35
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLAMINE
ACTIVE
36
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLAMINE
ACTIVE
37
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLAMINE
ACTIVE
38
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLAMINE
ACTIVE
39Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PREGNAN-20-ONE,3-ALPHA-AMINO-14-BETA-HYDROXY:
None
40
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGNAN-20-ONE,3-ALPHA-AMINO-14-BETA-HYDROXY:
WEAK ACTIVITY
41
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGNAN-20-ONE,3-ALPHA-AMINO-14-BETA-HYDROXY:
ACTIVE
42
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGNAN-20-ONE,3-ALPHA-AMINO-14-BETA-HYDROXY:
WEAK ACTIVITY
43
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGNAN-20-ONE,3-ALPHA-AMINO-14-BETA-HYDROXY:
ACTIVE
44
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PREGNAN-20-ONE,3-ALPHA-AMINO-14-BETA-HYDROXY:
WEAK ACTIVITY
45Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HOLOAMINE,15-ALPHA-HYDROXY:
None
46
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLOAMINE,15-ALPHA-HYDROXY:
ACTIVE
47
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLOAMINE,15-ALPHA-HYDROXY:
ACTIVE
48
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLOAMINE,15-ALPHA-HYDROXY:
ACTIVE
49
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLOAMINE,15-ALPHA-HYDROXY:
ACTIVE
50
ANTILEISHMANIASIS ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HOLOAMINE,15-ALPHA-HYDROXY:
ACTIVE
Show SPARQL Queries (1)